ONLINE OPINION POLL
Did you know that Adcock Ingram has moved offices to Midrand?
Yes
No
Click here to view results
 
 
Disclaimer
 
 
Milestones

These milestones relate to both Adcock Ingram Healthcare and
The Premier Pharmaceutical Company, pre-merger:

 
1890 E.J. Adcock Pharmacy opened its doors in Krugersdorp, which established the roots of what was destined to become South Africa's No. 1 pharmaceutical company.
   
1937 Ingram’s Camphor Cream launched.
   
1940 First pharmaceutical manufacturing facility commissioned.
   
1948 Relationship established with leading international company, Baxter Healthcare.
   

1950

Adcock Ingram listed on the Johannesburg Stock Exchange.

   
1977 Restan Laboratories signed a joint venture agreement with Dispersa (Switzerland) to market their Eye Care range in South Africa (today known as the Novartis Eye Care Range).
   
1978 Tiger Oats Limited acquired the Tannenbaum family shareholding, thus becoming the majority shareholder in Adcock Ingram.
   
1979 Critical Care Division commissioned South Africa's first medical grade plastic facility.
   
1982 Licence agreement signed for Jeyes range. The trade mark was later purchased for specific markets.
   
1986 Acquisition of Baxter's 40% share of the Critical Care Division.
   
1987 Acquisition of the Mer-National Division from Dow Chemicals Africa and the remaining 50% shareholding in Restan Laboratories.
   
  Myprodol, the locally developed and patented analgesic/anti-inflammatory was launched.
   
1988 Acquisition of Sterling Winthrop interests in South Africa which strengthened the Group's franchise in the OTC market with brands such as Panado, Phipps, Stearns and Wet Wipes.
   
1994 Acquisitions of Leppin, Laser, Pharmatec, Zurich Pharmaceuticals, Covan Pharmaceuticals and Salters as well as leading OTC brands in Zimbabwe. The latter included Panado and Cafemol.
Joint venture signed with Menarini which provided access to products such as Fastum Gel.
   
1996 Merger between Adcock Ingram and Premier Pharmaceuticals which created South Africa's leading supplier of Healthcare products.
   
1998 Adcock Ingram Critical Care celebrated its 50th anniversary.
   
1999 Construction of a new R25 million research and development centre commenced.
   
 

South Africa’s Competition Commission rejected Adcock Ingram’s bid to acquire South African Druggists.

   
2000 Adcock Ingram became a wholly owned subsidiary of Tiger Brands and was delisted from the JSE.
   
  Myprodol registered for use on social health insurance scheme in South Korea.
   
 

Investment of R26 million in a new research and development facility.

   
2001 Acquisition of Steri-Lab, which provided the base from which to develop a medical diagnostics business known as Adcock Ingram Scientific.
   
2002 Robertsons Homecare acquired, catapulting Adcock Ingram into the position of a leading player in the home care market with leading brands such as Doom, Airoma and the ICU range of household cleaners.
   
2003 Acquisition of Abbott Citro Soda business facilitated growth in the baby and consumer health markets.
   
 

Adcock Ingram Critical Care acquire the rights to market and distribute the ConvaTec range of specialty ostomy and wound care products in Southern Africa from Bristol Myers Squibb.

   
  Acquisition of the Park-Med generics business from Pfizer Laboratories which extended Adcock Ingram’s range of generic products and boosted the company’s franchise particularly in the generic cardiovascular and central nervous system markets.
   
2005 Adcock Ingram Critical Care acquires 74% of the Scientific Group. Partner, Brimstone Investment Corporation’s shareholding of 26% provides an important BEE (Black Economic Empowerment) component.
   
  Adcock Ingram acquires Donmed Pharmaceuticals.
   
  Adcock Ingram obtains marketing and distribution rights for Vita-thion energy tonic in South Africa and neighbouring territories.
   
  Holding company, Tiger Brands announces staff ownership scheme which is applauded as an important building block in the company’s commitment to broad based Black Economic Empowerment.
   
  Adcock Ingram OTC Academy of Learning launched to provide intensive and practical training to pharmacy personnel.
   
2006 Health icon and 7 times Tour de France winner, Lance Armstrong spearheads the launch of Unite 4 Health, a major Corporate Social Investment initiative.
   
  Research and Development facility achieves MCC accreditation. It is the first stand-alone facility to achieve such accreditation in Southern Africa.
   
  Adcock Ingram donates R4 million to Red Cross War Memorial Children’s Hospital and R2 million to the Heart of Soweto project as part of its Unite 4 Health corporate social investment initiative.
   
2007 Adcock Ingram launches its range of generic ARV products.
   
  Tiger Brands announces unbundling and planned re-listing of Adcock Ingram
   
2008 Adcock Ingram is listed on the main board at the Johannesburg Stock Exchange (JSE).
 
 
 
 
  Product A-Z
  Pharmaceutical Products
 
  Baby Care Products
 
  Personal Care Products
 
  Home Care Products
 
 
  Hospital Products
 
 
 
  Learn more about